Also trades as: 2616.HK (HKSE) · $vol 8M
CSPHF OTC
CStone Pharmaceuticals
1W: +4.9%
1M: +10.4%
3M: +26.9%
YTD: -15.4%
1Y: -24.5%
3Y: +51.0%
5Y: -32.0%
$0.76
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$343M
+41.7% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$343M
+47.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$609M
-239.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1.2B | -$1.9B | -$903M | -$367M | -$91M |
| Depreciation & Amort. | $15M | $23M | $45M | $58M | $50M |
| Stock-Based Comp. | $356M | $223M | $142M | $37M | -$3M |
| Change in Working Capital | $186M | $65M | $73M | -$140M | -$303M |
| Other Non-Cash Items | -$23M | -$8M | $31M | -$177M | $4M |
| Operating Cash Flow | -$508M | -$1.5B | -$612M | -$589M | -$343M |
| — Investing Activities — | |||||
| Capital Expenditures | -$71M | -$149M | -$102M | -$15K | $0 |
| Acquisitions (Net) | $18M | -$48M | $0 | $0 | $0 |
| Investment Purchases | -$359M | -$1.1B | -$683M | -$68M | -$255M |
| Investment Sales | $1.6B | $364M | $1.1B | $515M | $866K |
| Other Investing | $671K | $58M | $3M | $172M | $6M |
| Investing Cash Flow | $1.2B | -$827M | $365M | $620M | -$248M |
| — Financing Activities — | |||||
| Net Debt Issuance | $57M | $90M | $38M | $91M | -$786K |
| Stock Repurchased | -$22M | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$7M | -$14M | -$12M | -$45M | -$12M |
| Financing Cash Flow | $1.4B | $92M | $28M | $388M | -$13M |
| Net Change in Cash | $1.9B | -$2.3B | -$184M | $438M | -$609M |
| Cash End of Period | $3.0B | $743M | $559M | $997M | $388M |
| Free Cash Flow | -$580M | -$1.6B | -$714M | -$654M | -$343M |